| Class | Vasopressor |
|---|---|
| Chemistry |
Endogenous catecholamine |
| Routes of administration |
IV |
| Absorption |
Basically zero oral availabilty due to destruction by brush border enzymes in the gut (COMT and MAO) |
| Solubility |
pKa = 8.85; water-soluble |
| Distribution |
VOD = 0.12 L/kg, i.e. essentially confined to the circulating volume; 25% protein-bound |
| Metabolism |
Metabolised rapidly and completely by COMT and MAO |
| Elimination |
Metabolites are renally excreted. Half-life is ~2 minutes |
| Time course of action |
Very short acting, very rapid onset of effect |
| Target receptor |
Noradrenaline is highly selective for the alpha-1 receptor |
| Mechanism of action |
By binding to the alpha-1 receptor, noradrenaline increases the release of a secondary messenger (inositol triphosphate, IP3) which results in the release of calcium into the cytosol, and thus enhanced smooth muscle contractility. |
| Clinical effects |
Increased peripheral resistance, increased afterload, increased blood pressure; redistribution of blood flow from splanchnic circulation and skeletal muscle. |
| Literature reference |
TGA PI document |
| CICM details of understanding | Level 1 |
| Mentioned around Deranged Physiology |
Well, everywhere, but also: More pragmatic: Less pragmatic:
Sympathomimetics as the overarching trope, but also probably synaptic transmission and neurotransmitter systems |
| Related SAQs |
|